Stock listing

Neogenomics, Inc.

Selected listing: NEO · NASDAQ · USD · US

Neogenomics, Inc. (NASDAQ:NEO), Health Services. Latest release Oct 5, 2026: NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan.

NEO:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:NEO
Asset type: Stock
Sector: Health Services
Industry: Medical/Nursing Services
Exchange: NASDAQ
Currency: USD

About Neogenomics, Inc.

Neogenomics, Inc. is a publicly traded company listed under the ticker NEO, operating in the American market. Neogenomics specializes in cancer genetics and provides a range of diagnostic services to healthcare providers.

Latest news from Neogenomics, Inc.

NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan

October 5, 2026

NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

September 1, 2026

NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring

August 26, 2026

NeoGenomics Reports Second Quarter 2026 Results

July 28, 2026

NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS

July 20, 2026

All Neogenomics, Inc. news →

Events

Replays

NeoGenomics, Inc. (NEO) Q2 2026 Earnings Call
Tue, Jul 28, 2026 · 04:30 PM ET
Watch
NeoGenomics, Inc. (NEO) Q1 2026 Earnings Call
Tue, Apr 28, 2026 · 04:30 PM ET
Watch
NeoGenomics, Inc. (NEO) Q4 2025 Earnings Call
Tue, Feb 17, 2026 · 08:30 AM ET
Watch

Research Neogenomics, Inc.

Neogenomics, Inc. company profile

View the public company page for Neogenomics, Inc. on 6ix.

Neogenomics, Inc. news

Read company news and market updates connected to Neogenomics, Inc..

Neogenomics, Inc. investor events

Find investor webinars, events, and replay context for Neogenomics, Inc..